87 FR 173 pgs. 55040-55041 - Importer of Controlled Substances Application: Catalent CTS, LLC
Type: NOTICEVolume: 87Number: 173Pages: 55040 - 55041
Pages: 55040, 55041Docket number: [Docket No. DEA-1077]
FR document: [FR Doc. 2022-19394 Filed 9-7-22; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1077]
Importer of Controlled Substances Application: Catalent CTS, LLC
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Catalent CTS, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before October 11, 2022. Such persons may also file a written request for a hearing on the application on or before October 11, 2022.
ADDRESSES:
[top] The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on July 26, 2022, Catalent CTS, LLC, 10245 Hickman Mills Drive, Kansas City, Missouri 64137-1418, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
Controlled substance | Drug code | Schedule |
---|---|---|
Gamma Hydroxybutyric Acid | 2010 | I |
Marihuana Extract | 7350 | I |
Marihuana | 7360 | I |
Tetrahydrocannabinols | 7370 | I |
The company plans to import the listed controlled substances as dosage unit products for clinical trial studies. In reference to drug code 7370 (Tetrahydrocannabinols), the company plans to import a synthetic tetrahydrocannabinol. No other activities for these drug codes are authorized for this registration.
Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-19394 Filed 9-7-22; 8:45 am]
BILLING CODE P